Submitted by Jack Attack on Tue, 08/30/2016 - 3:24pm CHEST 2016: Update on IL-13 Targeted Therapies for the Management of Patients with Moderate-to-Severe AsthmaGroup: Subscribe to groupGroup visibility: Public - accessible to all site users
Facebook
Twitter
LinkedIn
Google+
Forward